Briefly, in 4 families, the mutant and wildtype alleles showed exact concordance with breast cancer occurrence for variants including PALB2 and BLM, but the remaining 9 families did not perfectly match with the presence of breast or ovarian disease (Supplementary Note 4; Supplementary Fig. 6). This evidence concerns the gene PALB2 and breast carcinoma.